ArticleJournal of experimental & clinical cancer research : CR2024

Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer.

Chiara Naro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.